McReynolds, Jayme R. http://orcid.org/0000-0002-4398-8691
Wolf, Colten P.
Starck, Dylan M.
Mathy, Jacob C.
Schaps, Rebecca
Krause, Leslie A.
Hillard, Cecilia J. http://orcid.org/0000-0002-9678-748X
Mantsch, John R. http://orcid.org/0000-0003-0099-1599
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DA045295, DA038663, DA015758, DA038663)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 28 October 2022
Revised: 1 April 2023
Accepted: 11 April 2023
First Online: 15 May 2023
Competing interests
: JRMc, CPW, DMS, JCM, LAK, and RS declare no potential competing interest. CJH is a member of the scientific board of directors of Phytecs, Inc; has equity in Formulate Biosciences, Inc and has received consultation fees from Pharmavite, LLC. JRM is a co-founder of and has equity in Promentis Pharmaceuticals, Inc.